Once you know the answer to these two questions, refer to this table to find the right
nanobody for your work.
Other labs are using
the nanobodies for projects ranging from identifying inhibitors of the zika virus to detecting bacterial species to classical genetic screens.
Are you ready to start using
nanobodies for your own research?
Not exact matches
According to Hansman, «this is, as far as we know, the first instance in which the molecular structure of a
nanobody - P domain complex has been determined
for norovirus.»
The implication of this proof - of - concept study of a novel technology
for reversing transporter - related drug resistance, they say, «is not limited to a single
nanobody used to demonstrate the technology, nor to a single drug, nor indeed to trypanosomiasis.»
You may have noticed the recent publication «A peptide tag - specific
nanobody enables high - quality labeling
for STORM imaging» of Virant et al (2018) in Nature Communications doi: 10.1038 / s41467 -018-03191-2, where
for the first time a peptide - tag specific
Nanobody was applied in dSTORM imaging: The authors have described and discussed... — Read more
Pleiner et al. have done the hard work
for you by immunizing an alpaca, isolating HCab antibodies from its serum, and meticulously screening, optimizing, and characterizing several anti-mouse and - rabbit
nanobodies.
Looking
for monoclonal primary antibodies to use with the secondary
nanobody toolbox?
Tang, Jonathan C.Y., et al. «A
nanobody - based system using fluorescent proteins as scaffolds
for cell - specific gene manipulation.»
If you just want to use the
nanobodies described in Pleiner et al, the key steps
for generating
nanobodies are outlined below; no alpaca required.
Looking
for primary monoclonal antibodies to use with the secondary
nanobody toolbox?
Nanobodies are like tiny antibodies which work just as well, if not better, than antibodies
for all of the above listed molecular techniques, but they can also be expressed in bacteria and extracted with common protein purification methods.
This refers to the number of cysteine sites the
nanobody has available
for conjugation to a specific label (see step 4
for more information).
See below
for a comparison of
nanobody, HCab, and traditional IgG antibody structures.
Staining with this multi-color staining workflow yields similar localization patterns as cells stained
for one target (compare
nanobodies staining in figure 4A vs 4B).
See figure 4A below
for comparison of this one - step staining with
nanobodies vs two - step staining with antibodies.
Read on to learn more about
nanobodies and how their structure and function compare to IgG antibodies, as well as how to produce them
for use in your lab.